JAN 12, 2019 12:02 AM PST

The Harms of Prescription Sleeping Pills

WRITTEN BY: Nouran Amin

In a study published by Frontiers in Behavioral Neuroscience, one of the main class of prescription sleeping pills was found to reduce the ability to wake up to dangerous alerting signals. In particular, the study found that half the participants could not wake-up from the sound of a fire alarm as loud as the sound of a vacuum next to their bed.

Even while sleeping the brain continuously processes sensory information and will wake us up if a threat was detected—such as a loud bang. The most widely prescribed sleeping pills are benzodiazepines, which will most likely not rouse in response to sensory input. "Benzodiazepines stimulate the widespread brain receptor GABA-A, which makes us sleepy but also suppresses off-target brain areas -- including the 'gatekeeper' that decides which sensory inputs to process," says study senior author, Professor Tomoyuki Kuwaki of Kagoshima University, Japan.

However, the last decade included the development of a new class of hypnotic drugs known as dual orexin receptor antagonists (DORAs). These drugs work by selectively targeting certain sleep/wake pathways in the brain—making them more advantageous in regards to safety over benzodiazepines, including a reduced 'hangover effect' that will less likely affect driving ability after use.

Learn more about the science of sleeping:

The researchers then hypothesized that the selectivity of DORAs could be a safer alternative, than another tested benzodiazepine called triazolam since it was confirmed in model mice that DORA-22 allowed the mice to sleep but still wake to a threat. "DORA-22 and triazolam had similar sleep promoting effects, extending the duration of deep sleep by 30-40% compared to placebo," reported Kuwaki. "As expected, arousal in response to these threatening stimuli was delayed significantly in the triazolam treatment, but not in the DORA-22 treatment, compared to placebo.

However, to help confirm the safety and efficacy of the sleep-promoting effect of DORA in humans—clinical studies are needed after approval. "Although it remains to be seen whether DORAs have the same properties when used in humans, our study provides important and promising insight into the safety of these hypnotics."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
MAY 14, 2020
Cancer
MAY 14, 2020
New hope for immunotherapy for pediatric brain cancer
Pediatric brain cancer is an especially tough pill to swallow. While one in four children does not survive medulloblasto ...
MAY 25, 2020
Genetics & Genomics
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
JUN 13, 2020
Cancer
JUN 13, 2020
Examining Cancers Effect on the Immune System for Prognostic Use
Most think of cancer in the context of where it is on the body like breast or pancreatic cancer. There are several more ...
JUN 18, 2020
Drug Discovery & Development
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
JUL 02, 2020
Cardiology
JUL 02, 2020
Managing the Mitochondria After a Heart Attack
Heart attacks are an unfortunately common occurrence across the country. One of the biggest consequences of a heart atta ...
Loading Comments...